Talis Biomedical Corp - TLIS Company Short-Term Debt

talis.bio (TLIS) - corporate logo

The Talis Biomedical (TLIS) price chart demonstrates the dynamics of a company that generates revenue through the supply of express systems, creating long-term clinic dependency on consumables. The diversification of diagnostic panels allows the company to minimize seasonality risks. Meanwhile, the indicator stands at 0.00, and the current operational transformation is prompting caution among shareholders, forcing management to focus on preserving the value of existing resources.

TLIS: Talis Biomedical Short-Term Debt 07/04/2022 - 09/07/2024

Summary analytical data breakdowns for Talis Biomedical Corp. (TLIS)

- price and consensus price forecast:
Stock Price Talis Biomedical Corp|TLIS - Analyst Target Range
- market capitalization data:
Market Value Talis Biomedical Corporation|TLIS - Business Value
- book capitalization data:
Net Assets per Single Share Talis Biomedical|TLIS - Total Stockholders' Equity|Market Value to Book Value Ratio talis.bio|TLIS - Company Total Asset Base
- debt and liquidity data:
Total Debt to Equity Ratio Talis Biomedical|TLIS - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Talis Biomedical Corp|TLIS - Company Total Debt Obligations|Debts to Book Capitalization Talis Biomedical Corporation|TLIS - Company Long-Term Liabilities|Company Current Liabilities Talis Biomedical
Analysis of all company metrics:talis.bio - TLIS
Original product of Talis Biomedical Corp.

This indicator captures the total liabilities of Talis Biomedical (TLIS) due within the next year, providing an objective assessment of the business's current liquidity and credit burden. Analyzing financial debt with a maturity of up to 12 months helps determine the company's stability, which, due to its insulation from macroeconomic shocks and steady demand for medtech, effectively utilizes borrowed capital as a defensive asset.

Competitor analysis

Company Short-Term Debts ABT|TMO: Short-Term Indebtedness|Company Short-Term Debt GE Healthcare Corp|MTD (Mettler Toledo Inc) - Company Short-Term Indebtedness|Company Short-Term Debt WAT (Waters Corporation)|Short-Term Debt TECH|BRKR (Bruker) - Company Short-Term Debt|Short-Term Debt Volume Azenta Inc AZTA|Company Current Liabilities Varex (VREX)|Amount of Current Liabilities Semler SMLR|Company Short-Term Debts BFLY (Butterfly Network, Inc.)|MLAB - Short-Term Debt Volume|QSI (Quantum-Si Incorporated) - Company Short-Term Debts|Company Current Liabilities Nano-X Imaging|QTRX - Company Current Liabilities|Company Short-Term Loans and Borrowings MASS|Company Short-Term Debt CV (CapsoVision Inc)|Company Current Liabilities maxcyte.com (MXCT)|RPID: Company Short-Term Debts|Short-Term Debt Seer Inc SEER|Hyperfine Corp (HYPR) - Company Short-Term Debts|FONR - Company Short-Term Indebtedness|daxor.com - Company Short-Term Debts|spectral-ai.com (MDAI) - Short-Term Debt Volume|Company Short-Term Debts VIVS|Company Current Liabilities Aclarion Inc|Company Short-Term Debts AKYA|Company Short-Term Debts THMO (Cesca Therapeutics)|Company Short-Term Debt T2 Biosystems, Inc. TTOO